ライフサイエンスコーパス: Phoenix

1 ms) and lower-than-desired CA (MicroScan and Phoenix).

2 Vitek 2), LEV (Phoenix), and CAZ (MicroScan, Phoenix).

3 (AST) systems (i.e., Vitek 2, MicroScan, and Phoenix).

4 n (Vitek 2 and MicroScan), and TGC (Vitek 2, Phoenix).

5 ls (Triticeae), sesame (Sesamum), and dates (Phoenix).

6 explore future water-shortage conditions in Phoenix.

7 t a single most likely or optimal future for Phoenix.

8 est-incidence areas were in the periphery of Phoenix.

9 for CP(bla)(KPC)-CRE and non-CP CRE with BD Phoenix.

10 amming, and how frequently they attended The Phoenix.

11 ied just over half (54%) of census tracts in Phoenix.

12 perform susceptibility testing using the BD Phoenix.

13 concentration higher and MICs determined by Phoenix 1 log2 concentration lower.

14 o the species level: MALDI Biotyper, 46%; BD Phoenix, 35%; and API 20 Strep, 26%.

15 sitive and 1,106 gram-negative) and 1,927 by Phoenix (409 gram-positive and 1,518 gram-negative).

16 clavulanate disk augmentation (9/19) and BD Phoenix (5/19).

17 MIC value of 1 mg/liter (74.1%), whereas the Phoenix (76%) and Vitek 2 (20%) systems had a tendency t

18 ing" a likely carbapenemase were 100%/0% (BD Phoenix), 82 to 85%/6 to 19% (MicroScan), and 74%/38% (V

19 he exception of SXT by MicroScan (98.1%) and Phoenix (98.1%) and MIN by MicroScan (100%) and Phoenix

20 enix (98.1%) and MIN by MicroScan (100%) and Phoenix (99.1%).

21 The CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopido

22 gement of Platelet Inhibition), and CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopido

23 We developed PHOENIX, a modeling framework based on neural ordinary d

24 erminal kinase pathway when transfected into Phoenix-A cells (derivatives of 293 cells), similar to m

25 In addition, in Phoenix-A, NIH-3T3, and Hela cells, overexpression of wi

26 In Experiment 1, the dolphins Phoenix and Akeakamai processed the identity of a cued o

27 For the 308 common isolates, the BD Phoenix and Bruker Biotyper correctly identified 294 (95

28 For species identification, the BD Phoenix and Bruker Biotyper correctly identified 93% of

29 for CP(bla)(KPC)-CRE and non-CP CRE with BD Phoenix and DD tests.

30 SI tests, were the reference methods for the Phoenix and VITEK 2 evaluations.

31 Current BD Phoenix and Vitek 2 methodologies were assessed as scree

32 The inclusion of cefoxitin in the Phoenix and Vitek 2 panels has optimized the detection o

33 acillin susceptibility," ranging from 54.1% (Phoenix) and 83.8% (Vitek 2) to 92.8% (WalkAway).

34 rogen suppression (AS) improves event- (EFS, Phoenix) and clinical disease-free survival (DFS) of int

35 in duplicate by automated broth dilution (BD Phoenix) and disc diffusion.

36 Phoenix automated susceptibility system (BD Phoenix) and disk diffusion (DD) relative to reference b

37 errors (ME) were >3% for SXT (Vitek 2), LEV (Phoenix), and CAZ (MicroScan, Phoenix).

38 ial MIC testing systems (MicroScan, Vitek 2, Phoenix, and Etest) to detect vancomycin MIC values of <

39 all 3 tertiary academic centers (Rochester, Phoenix, and Jacksonville) were included in the study.

40 , we tested the abilities of the Vitek 2, BD Phoenix, and Kirby Bauer disk diffusion tests to detect

41 AM trial at three medical centres in Boston, Phoenix, and Los Angeles, USA.

42 th contrasting background climates (Toronto, Phoenix, and Miami), under contemporary and end-of-centu

43 tended to be more accurate than the Vitek 2, Phoenix, and MicroScan automated systems; but errors wer

44 The BD Phoenix AP instrument reduced the manual setup time for

45 the urbanized Maricopa County (metropolitan Phoenix), Arizona, USA.

46 he study was conducted at YMCA facilities in Phoenix, Arizona from May 2016 to March 2020.

47 Using Phoenix, Arizona light rail as a case study, an integrat

48 y infusion centers at Mayo Clinic Arizona in Phoenix, Arizona, and the University of Mississippi Medi

49 Samples were collected in Phoenix, Arizona, at an ambulatory clinic and at retail

50 1,500-3,500 square feet in area, located in Phoenix, Arizona, built in 2002 and retired in 2051.

51 th counties of Wisconsin; and in 2005 in the Phoenix, Arizona, metropolitan area.

52 ctions from 11 air sampling sites across the Phoenix, Arizona, metropolitan area.

53 In 2020, the City of Phoenix, Arizona, piloted a "cool pavement" program usin

54 dical Center, a 650-bed teaching hospital in Phoenix, Arizona.

55 and Digestive and Kidney Diseases (NIDDK) in Phoenix, Arizona.

56 cago, Illinois; Los Angeles, California; and Phoenix, Arizona.

57 oss Atlanta, Georgia; Detroit, Michigan; and Phoenix, Arizona.

58 iabetes and Digestive and Kidney Diseases in Phoenix, Arizona.

59 onal dispatch centers servicing metropolitan Phoenix, Arizona.

60 ing data on heat-related hospitalizations in Phoenix, Arizona.

61 nual meeting of the Society of Toxicology in Phoenix, Arizona.

62 ions in Rochester, Minnesota; Scottsdale and Phoenix, Arizona; and Jacksonville, Florida; and Mayo Cl

63 e enrolled 782 patients through hospitals in Phoenix, Arizona; Boston; and Pittsburgh; 489 had histol

64 cted in Rochester, Minnesota; Scottsdale and Phoenix, Arizona; Jacksonville, Florida; and community-b

65 onducted at 3 clinical centers in Tucson and Phoenix, Arizona; Pittsburgh, Pennsylvania; and Birmingh

66 Paul, Minnesota; Philadelphia, Pennsylvania; Phoenix, Arizona; Seattle, Washington; and St. Louis, Mi

67 could empirically test participation in The Phoenix as a laudable strategy for combatting relapse an

68 From these data, the Phoenix AST results demonstrated a high degree of agreem

69 The performance of the BD Phoenix Automated Microbiology System (BD Diagnostic Sys

70 We evaluated the Phoenix automated microbiology system (BD Diagnostic Sys

71 The Phoenix automated microbiology system (BD Diagnostics, S

72 level using standard biochemical tests and a Phoenix automated microbiology system (BD Diagnostics, S

73 ity testing was initially performed with the Phoenix automated microbiology system (BD Diagnostics, S

74 iety of phenotypic methods, including the BD Phoenix automated microbiology system (BD Diagnostics, S

75 This multicenter study evaluated the BD Phoenix Automated Microbiology System STREP panel (BD Di

76 We compared the BD Phoenix automated microbiology system to the Bruker Biot

77 mpare the cefepime testing performance of BD Phoenix automated susceptibility system (BD Phoenix) and

78 Joseph's Hospital and Medical Center (Phoenix, AZ) (6 males and 6 females), using a head-mount

79 g medical records from Mayo Clinic Hospital (Phoenix, AZ) and contacting local infectious diseases sp

80 (Translational Genomics Research Institute, Phoenix, AZ) and Dr. Nicholas Dracopoli (Bristol-Myers S

81 , immunohistochemistry (Caris Life Sciences, Phoenix, AZ).

82 , Raleigh, NC, St. Paul, MN, Pittsburgh, PA, Phoenix, AZ, and Portland, OR) in two physiographic sett

83 glioblastoma from two Mayo Clinic campuses (Phoenix, AZ, and Rochester, MN, USA).

84 C, Okefenokee, GA, Bondville, IL, Mingo, MO, Phoenix, AZ, San Gabriel, CA, Crater Lake National Park,

85 Through a case study of a desert city, i.e., Phoenix, AZ, this study provides a novel application of

86 hester (MN, USA) and Mayo Clinic in Arizona (Phoenix, AZ, USA) comparing conventional fractionated (5

87 partment of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA, and the US National Cancer Institute.

88 two children's hospitals in Houston, TX and Phoenix, AZ, USA.

89 done at the Banner Alzheimer's Institute in Phoenix, AZ, USA.

90 of 100 adults (age 18-70 y, 55% females) in Phoenix, AZ.

91 y of 100 adults (age: 18-70 y, 55% women) in Phoenix, AZ.

92 e sites in the United States (Rochester, MN; Phoenix, AZ; and Jacksonville, FL).

93 can WalkAway (Dade, West Sacramento, CA), BD Phoenix (BD Diagnostic Systems, Sparks, MD), VITEK (bioM

94 The BD Phoenix (BD Diagnostics, Sparks, MD) and Vitek 2 (bioMer

95 We evaluated the Phoenix (BD, Sparks, MD), MicroScan (Beckman Coulter, Sa

96 ns), 91.9% (Vitek 2; bioMerieux), and 64.9% (Phoenix, BD).

97 altonics), API 20 Strep (bioMerieux), and BD Phoenix (Becton, Dickinson).

98 , there was a significant benefit for DE for Phoenix BF.

99 r tertile PORTOS, there was no difference in Phoenix biochemical failure (BF).

100 BD Phoenix, bioMerieux Vitek 2, and Beckman Coulter MicroSc

101 ern, PA], Trep-Sure enzyme immunoassay [EIA; Phoenix Biotech, Oakville, Ontario, Canada], Trep-Chek E

102 rep-Chek EIA [Phoenix Biotech], Trep-ID EIA [Phoenix Biotech], and Treponema ViraBlot IgG [Viramed Bi

103 , Oakville, Ontario, Canada], Trep-Chek EIA [Phoenix Biotech], Trep-ID EIA [Phoenix Biotech], and Tre

104 We also assessed the scalability of PHOENIX by modeling genome-scale GRNs for breast cancer

105 ipulation time per isolate was 89.5 s for BD Phoenix by the use of the AP instrument and 101 s for Vi

106 benefits of transit-oriented developments in Phoenix can range from 1.7 to 230 Gg CO2e depending on t

107 Our new tool, pHoenix, can functionally replace endogenous proton pump

108 base tissues of the Canary Island date palm (Phoenix canariensis) contain lignins with the most compl

109 In CHAMPION PHOENIX, cangrelor reduced the odds of major adverse car

110 ength IL-5Ralpha and betac were expressed in Phoenix cells as chimeric proteins fused to enhanced cya

111 aneous Coronary Intervention [PCI] [CHAMPION PHOENIX] [CHAMPION]: NCT01156571).

112 In Phoenix chickens, superlong main sickle feathers exhibit

113 a wide-field digital retinal imaging system (Phoenix Clinical ICON Paediatric Retinal Camera) by a tr

114 ve, double-blind, active-controlled CHAMPION PHOENIX (Clinical Trial Comparing Cangrelor to Clopidogr

115 Here we present observations of the Phoenix cluster(17) using the James Webb Space Telescope

116 y may contribute to the understanding of how phoenix colonies are able to emerge and survive in the p

117 novel antibiotic tolerant variants known as phoenix colonies as well as variants similar to viable b

118 Phoenix colonies were found to have a single nucleotide

119 h when knocked out led to a complete lack of phoenix colonies.

120 In this study, the mechanisms behind phoenix colony and VBNC-like colony emergence were furth

121 ally expressed genes that may play a role in phoenix colony emergence.

122 HAMPION-PCI, CHAMPION-PLATFORM, and CHAMPION-PHOENIX) compared cangrelor with control (clopidogrel or

123 The BD Phoenix correctly identified 363 (83%) and 330 (75%) iso

124 ced greater support, this study suggests The Phoenix could be an effective environment for creating t

125 BD Phoenix CPO detect (CPO detect) detects and classifies c

126 The current study evaluated the automated BD Phoenix CPO Detect and the manual bioMerieux Rapidec Car

127 Only BD Phoenix CPO Detect classified carbapenemases.

128 BD Phoenix CPO Detect provides novel advantages such as aut

129 BD Phoenix CPO Detect was 68.6% specific and Rapidec Carba

130 after radiation therapy and not meeting the Phoenix criteria (n = 22), and after other primary local

131 hemical recurrent prostate cancer defined by Phoenix criteria after external-beam radiotherapy or bra

132 The Phoenix criteria defined biochemical recurrence-free sur

133 in the subgroup of patients not meeting the Phoenix criteria for BCR were 80% (4/5), 90% (9/10), 100

134 after radiation therapy without meeting the Phoenix criteria for BCR, after other definitive local t

135 t, was defined from entry until PSA relapse (Phoenix criteria) and clinical relapse by imaging or dea

136 erapeutic Radiology and Oncology [ASTRO] and Phoenix criteria), local failure, distant metastasis, ca

137 ciety for Therapeutic Radiation Oncology and Phoenix criteria.

138 Date palm (Phoenix dactylifera L.) and its fruit possess sociocultu

139 Dates (Phoenix dactylifera L.) are distributed worldwide as maj

140 Date palm (Phoenix dactylifera L.) is a major fruit crop of arid re

141 In the present study, date (Phoenix dactylifera L.) seed oil was investigated for it

142 The date palm (Phoenix dactylifera L.), famed for its sugar-rich fruits

143 Seven date palm seeds (Phoenix dactylifera L.), radiocarbon dated from the four

144 Date palms (Phoenix dactylifera) are an important fruit crop of arid

145 Date palms (Phoenix dactylifera) are the most significant perennial

146 ined as biochemical failure according to the Phoenix definition (PSA >=2 ng/mL over the nadir PSA), c

147 nce was used to calculate BF rates using the Phoenix definition, as well as PCSD.

148 herapeutic Radiology and Oncology [ASTRO] or Phoenix definitions), local failure, distant failure, or

149 ubated for 6 or 24 h prior to Sensititre and Phoenix demonstrated 100% essential agreement.

150 gorical agreement levels for VITEK 2, Etest, Phoenix, disk diffusion, and VITEK were 93.0%, 90.0%, 89

151 Phoenix egAST performance for Pseudomonas aeruginosa rev

152 The Phoenix ESBL confirmatory test and unmodified expert sys

153 Phoenix et al. (1959) reported that treating pregnant gu

154 The VITEK 2 and Phoenix extended-spectrum beta-lactamase (ESBL) detectio

155 An analysis of the Phoenix Fire Department Regional Dispatch Center records

156 med out-of-hospital cardiac arrests from the Phoenix Fire Department Regional Dispatch Center text fi

157 a super-photostable and bright organic dye, Phoenix Fluor 555 (PF555), which exhibits an order-of-ma

158 Bruker Biotyper overall outperformed the BD Phoenix for identification of gram-negative bacilli to t

159 ver, the Bruker Biotyper outperformed the BD Phoenix for identification of infrequently isolated gram

160 at participants who had been involved in The Phoenix for longer experienced greater support, this stu

161 -GALV), and we evaluated vectors produced by Phoenix-GALV for their ability to transduce hematopoieti

162 dotype retrovirus vectors produced by either Phoenix-GALV or by the NIH 3T3-derived packaging cell li

163 with a gibbon ape leukemia virus pseudotype (Phoenix-GALV), and we evaluated vectors produced by Phoe

164 ion of baboon CD34(+) cells, suggesting that Phoenix-GALV-derived oncoretroviral vectors may be even

165 ing cells was significantly higher using the Phoenix-GALV-derived vector as compared with the PG13-de

166 In 3 additional baboons we compared Phoenix-GALV-derived vectors to more recently developed

167 tilineage engraftment of cells transduced by Phoenix-GALV-pseudotype vectors.

168 a personal cost and through the existence of phoenix genes, which rescue cooperative systems from sel

169 n minutes in up to 96% yield in an automated Phoenix high-temperature and high-pressure continuous fl

170 ions (ASTRO HR 1.073 [1.018-1.131], p=0.008; Phoenix HR 1.073 [1.014-1.134], p=0.014); and any failur

171 overall percentages of agreement between the Phoenix ID results and the MicroScan results at the genu

172 rnaround times for positive cultures, and BD Phoenix identification and antimicrobial susceptibility

173 rall, there was good correlation between the Phoenix instrument and the MicroScan system for the ID a

174 We evaluated the performance of the Phoenix instrument in comparison with that of the MicroS

175 e); one false positive was obtained with the Phoenix instrument.

176 The Phoenix is a non-profit organization whose mission is to

177 of the world's largest marine reserves, the Phoenix Islands Protected Area (PIPA), and find that fis

178 The Phoenix Islands Protected Area (PIPA), one of the world'

179 Like a phoenix, lactate has risen to major importance in 21st c

180 The discovery by the Phoenix Lander of calcium and magnesium perchlorates in

181 Given the Phoenix lander's observation of an active water cycle on

182 has been identified in the soils around the Phoenix landing site by scanning calorimetry showing an

183 or errors (VME) were >3% for SXT (MicroScan, Phoenix), LEV (MicroScan), and CAZ (all systems).

184 The Wet Chemistry Laboratory on the Phoenix Mars Lander performed aqueous chemical analyses

185 person was in recovery, if that person was a Phoenix member, and how often that person provided suppo

186 covery (beta = 0.451, p < 0.001), and fellow Phoenix members (beta = 0.303, p = 0 .001).

187 Second, because findings show that fellow Phoenix members provided participants more support, and

188 After controlling for network size, Phoenix members reported the most support provision from

189 factors related to support provision within Phoenix members' social networks.

190 (79 men, 138 women) were recruited from the Phoenix metropolitan area (age range = 17-92 years).

191 automated susceptibility testing systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2; two lab

192 genotypic-phenotypic discordant CRE, the BD Phoenix MICs and DD susceptibility results trended highe

193 The Phoenix mission investigated patterned ground and weathe

194 Phoenix (n = 167 isolates) demonstrated 84.4% categorica

195 rformance of egAST on gram-positive (n = 49, Phoenix; n = 46 Sensititre) and gram-negative (n = 81 Ph

196 n = 46 Sensititre) and gram-negative (n = 81 Phoenix; n = 61 Sensititre) patient-derived isolates wit

197 -Line Data Registry (COLD Registry) used the Phoenix (nadir + 2 ng/ml definition) to report 5-year bi

198 aneous Coronary Intervention [PCI] [CHAMPION PHOENIX]; NCT01156571).

199 ploying disk augmentation, Etest, and the BD Phoenix NMC/ID-132 panel.

200 y major errors (VMEs) were calculated for BD Phoenix (NMIC-306 Gram-negative panel) and DD relative t

201 all efficacy seen with cangrelor in CHAMPION PHOENIX occurred early and during the period of time in

202 for between 3% (Atlanta) and more than 50% (Phoenix) of the total urban population in present and fu

203 Sensititre) and an automated AST system (BD Phoenix) on isolates incubated for 6 h (early growth AST

204 ll, as additional vesicle acidification with pHoenix only slightly increased the quantal size.

205 Organisms were inoculated onto the Phoenix panel according to the manufacturer's instructio

206 l met standard acceptance criteria while the Phoenix panel had low CA for all tested BL/BLIs compared

207 CA of the Phoenix panel was 83.0% for CZA and 85.7% for CT.

208 The Phoenix panel was biased towards under-calling CZA resis

209 by the reference methods were 99.8% for the Phoenix panels and 99.7% for the Vitek 2 cards.

210 the performance of commercial Sensititre and Phoenix panels for CZA, CT, and IMR susceptibility testi

211 The Phoenix panels were inoculated according to the manufact

212 enterococci were correctly identified by the Phoenix panels.

213 f over $520 (Seattle) to a net loss of $800 (Phoenix) per building annually.

214 costs range from -$1.60 (Seattle) to $11.9 (Phoenix) per m(3) of rainwater yield, resulting in a pot

215 . aureus isolates were tested in parallel on Phoenix PMIC/ID-102 panels and Vitek 2 AST-GP66 cards.

216 hic information, when they started attending Phoenix programming, and how frequently they attended Th

217 potential of methanolic flower extracts from Phoenix pusilla (Pp-Fe), its major compound, and malathi

218 e optimal management of platelet inhibition) PHOENIX randomized 11 145 patients to cangrelor or clopi

219 formance of Vitek 2, MicroScan WalkAway, and Phoenix relative to that of reference broth microdilutio

220 In Experiment 2, Phoenix reliably responded to a cued object in alternate

221 We present a survey of Phoenix remains in the archaeobotanical record which sup

222 GHG emissions of the U.S. cities Boston and Phoenix, respectively, for a 50-year analysis period.

223 , the rate of complete agreement between the Phoenix results and the MicroScan results was 89.1%; the

224 , the rate of complete agreement between the Phoenix results and the MicroScan results was 97%; the r

225 For Enterobacterales, egAST using Phoenix revealed 1.3% minor errors (MiE), 0.17% major er

226 oliferation of surrounding cells through the Phoenix Rising (PR) pathway.

227 Like a phoenix rising from the ashes, this amazing catalytic re

228 We demonstrated PHOENIX's flexibility by modeling regulation of oscillat

229 mmercial MIC test systems (Etest, MicroScan, Phoenix, Sensititre, Vitek Legacy, and Vitek 2 systems)

230 epsis, defined as suspected infection with a Phoenix Sepsis Criteria (PSC) score of 2 or more or deat

231 The Phoenix sepsis criteria for sepsis and septic shock in c

232 The Phoenix sepsis criteria had a sensitivity of 55.0% (95%

233 The small proportion of children meeting Phoenix sepsis criteria, missingness of data, timing of

234 Overall, 306 children (4.9%) met the Phoenix sepsis criteria, of whom 33 (10.8%) died in the

235 dren hospitalized with suspected sepsis, the Phoenix Sepsis Score and sepsis criteria had similar per

236 The novel Phoenix Sepsis Score and sepsis criteria were derived an

237 In this population, the worst Phoenix Sepsis Score calculated over the first 24 hours

238 A Phoenix Sepsis Score of at least 2 identified potentiall

239 Children with a Phoenix Sepsis Score of at least 2 points had in-hospita

240 s that sepsis in children be identified by a Phoenix Sepsis Score of at least 2 points in children wi

241 Coagulation data for the calculation of the Phoenix Sepsis Score were missing in more than 85% of ch

242 ing-assisted paediatric sepsis criteria (the Phoenix Sepsis Score) have excluded kidney function enti

243 ed by at least 1 cardiovascular point in the Phoenix Sepsis Score, which included severe hypotension

244 able is highly variable within the potential Phoenix spacecraft landing ellipses, and is likely to be

245 The Mars Phoenix spacecraft measurements of carbon isotopes [refe

246 nt modern human diets, including date palms (Phoenix spp.), legumes, and grass seeds (Triticeae), whe

247 rvey of the spatially thin, dynamically cold Phoenix stellar stream in the halo of the Milky Way.

248 The properties of the Phoenix stream are consistent with it being the tidally

249 The Phoenix stream thus represents the debris of the most me

250 tment biopsies from patients enrolled in the PHOENIX study (n = 584) to define the extent to which th

251 m the addition of ibrutinib to R-CHOP in the PHOENIX study, independent of LymphGen classification.

252 reement (0 +/- dilution) was highest for the Phoenix system (66.2%) and the MicroScan turbidity metho

253 , and G; and 20 other streptococci) with the Phoenix system and a broth microdilution reference metho

254 rument reduced the manual setup time for the Phoenix system by 50%.

255 The Phoenix system compares favorably to traditional methods

256 The Phoenix system compares favorably to traditional methods

257 All six were flagged by the Phoenix system expert rules.

258 We evaluated the accuracy of the BD Phoenix system for the identification (ID) and antimicro

259 The Phoenix system is a reliable method for the ID and AST o

260 The Phoenix system provided reliable and rapid AST results f

261 nal biochemical testing, the accuracy of the Phoenix system was determined to be 100%.

262 In 16 instances (9 on the Phoenix system, 7 on the Vitek 2 system), an oxacillin M

263 s spp., there were no MiE, ME, or VME on the Phoenix system, whereas early growth Sensititre showed 3

264 lenge isolates, versus the 6 detected by the Phoenix system.

265 n-resistant enterococci were detected by the Phoenix system.

266 isolates were incorrectly identified by the Phoenix system; 10 of these were incorrectly identified

267 y undercalled resistance); the MicroScan and Phoenix systems and Etest tended to categorize susceptib

268 The Biotyper and Phoenix systems correctly identified 99.9% and 99.5% to

269 The Bruker Biotyper and BD Phoenix systems were evaluated for identification of 1,0

270 hird arm of the study was conducted with the Phoenix test using two normally inactive expert rules in

271 , although fewer VMEs were observed with the Phoenix than with the Vitek 2.

272 s, designated phx (for the mythological bird Phoenix that rises from its ashes), were isolated.

273 For Phoenix, the EAs of individual antimicrobial agents rang

274 The longer someone had been a member of The Phoenix, the more likely they were to report greater sup

275 d introgressed segments from the Cretan palm Phoenix theophrasti, a crucial genetic feature of the mo

276 nents from Middle Eastern P. dactylifera and Phoenix theophrasti, a wild relative endemic to the East

277 and pAmpC genes for Etest (four of five), BD Phoenix (three of five), and disk augmentation (one of f

278 to cangrelor or clopidogrel in the CHAMPION PHOENIX trial (Cangrelor versus Standard Therapy to Achi

279 Management of Platelet Inhibition (CHAMPION) PHOENIX trial demonstrated superiority of cangrelor in r

280 Data from the CHAMPION PHOENIX trial of patients undergoing elective or nonelec

281 Analysis of biopsies from Phoenix trial patients revealed three previously charact

282 In the CHAMPION PHOENIX trial, cangrelor reduced the primary composite e

283 In the large-scale CHAMPION PHOENIX trial, the occurrence of IPST was strongly predi

284 Management of Platelet Inhibition (CHAMPION PHOENIX) trial randomized 11,145 patients undergoing ele

285 HAMPION PCI, CHAMPION PLATFORM, and CHAMPION PHOENIX) trials of patients undergoing elective or nonel

286 PHOENIX uses a combination of user-defined prior knowled

287 d to other organelles, as demonstrated for a pHoenix variant that allows light-activated acidificatio

288 using disk diffusion, Etest, as well as the Phoenix, Vitek 2, and MicroScan automated systems, and c

289 The average times to results for Phoenix, Vitek 2, and the manual methods were 12.1 h, 9.

290 ined by the reference method) for MicroScan, Phoenix, VITEK 2, Etest, and VITEK were 99.0%, 95.8%, 92

291 The categorical agreements (CA) of Phoenix, Vitek 2, MicroScan, and Etest for penicillin we

292 The 5-year FFP-Phoenix was 88.0% (95% CI, 84.2 to 91.9) with COMBO comp

293 The overall CA for Phoenix was 99.3% (1 very major error [VME] and 29 minor

294 CHAMPION PHOENIX was a double-blind, placebo-controlled trial tha

295 Phoenix was errorless on first trials in this task.

296 ermal and evolved gas analyzer (TEGA) aboard Phoenix were successful in detecting organics in the Mar

297 cies level, respectively, compared to the BD Phoenix, which identified only 69 (52%) and 45 (34%) iso

298 KPC)-CRE isolates (n = 64) were <90% with BD Phoenix while among non-CP CRE isolates (n = 58), EA and

299 and noncompartmental PKs were analyzed using Phoenix WinNonlin.

300 as 85.0% with 4.3% VMEs and 0.8% MEs for the Phoenix with FDA breakpoints.